As of 2026-09-17, the EV/EBITDA ratio of Ionis Pharmaceuticals Inc (IONS) is -14.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IONS's latest enterprise value is 9,015.07 mil USD. IONS's TTM EBITDA according to its financial statements is -610.22 mil USD. Dividing these 2 quantities gives us the above IONS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 22.1x | 14.2x |
| Forward P/E multiples | 13.6x - 24.1x | 18.6x |
| Fair Price | (59.50) - (90.49) | (69.72) |
| Upside | -232.7% - -301.8% | -255.5% |
| Date | EV/EBITDA |
| 2026-09-16 | -14.77 |
| 2026-09-15 | -15.43 |
| 2026-09-14 | -16.57 |
| 2026-09-11 | -17.33 |
| 2026-09-10 | -17.72 |
| 2026-09-09 | -17.82 |
| 2026-09-08 | -18.01 |
| 2026-09-04 | -18.38 |
| 2026-09-03 | -18.39 |
| 2026-09-02 | -19.26 |
| 2026-09-01 | -18.87 |
| 2026-08-31 | -19.00 |
| 2026-08-28 | -19.19 |
| 2026-08-27 | -19.56 |
| 2026-08-26 | -19.82 |
| 2026-08-25 | -19.87 |
| 2026-08-24 | -19.46 |
| 2026-08-21 | -18.83 |
| 2026-08-20 | -18.56 |
| 2026-08-19 | -19.12 |
| 2026-08-18 | -18.80 |
| 2026-08-17 | -18.53 |
| 2026-08-14 | -18.15 |
| 2026-08-13 | -17.78 |
| 2026-08-12 | -17.96 |
| 2026-08-11 | -17.65 |
| 2026-08-10 | -18.07 |
| 2026-08-07 | -17.97 |
| 2026-08-06 | -17.40 |
| 2026-08-05 | -17.32 |
| 2026-08-04 | -17.56 |
| 2026-08-03 | -17.40 |
| 2026-07-31 | -16.66 |
| 2026-07-30 | -17.07 |
| 2026-07-29 | -17.28 |
| 2026-07-28 | -17.62 |
| 2026-07-27 | -17.80 |
| 2026-07-24 | -17.96 |
| 2026-07-23 | -17.78 |
| 2026-07-22 | -17.27 |
| 2026-07-21 | -17.10 |
| 2026-07-20 | -16.98 |
| 2026-07-17 | -17.37 |
| 2026-07-16 | -17.45 |
| 2026-07-15 | -17.47 |
| 2026-07-14 | -17.52 |
| 2026-07-13 | -18.02 |
| 2026-07-10 | -18.43 |
| 2026-07-09 | -20.06 |
| 2026-07-08 | -25.56 |